Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01115452 · ClinicalTrials.gov registry record · Phase 2
Efficacy of Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT01115452 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 32 participants.
The verdict
NCT01115452, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
An exploratory study investigating the direct application of potassium nitrate (KNO3) solutions of different concentrations in reducing dentine hypersensitivity.
Interventions
- OTHER Sterile water
- DRUG 5% Potassium nitrate
- DRUG 2.5% Potassium nitrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-09 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01115452
The ClinicalTrials.gov registry entry for NCT01115452 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sterile water is the first listed.
NCT01115452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01115452 about?
NCT01115452 is a clinical study titled "Efficacy of Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity". An exploratory study investigating the direct application of potassium nitrate (KNO3) solutions of different concentrations in reducing dentine hypersensitivity.
What is the current status of trial NCT01115452?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2009-09. Estimated completion is 2009-10.
What interventions are being tested in trial NCT01115452?
The interventions under investigation include: Sterile water (OTHER), 5% Potassium nitrate (DRUG), 2.5% Potassium nitrate (DRUG).
Who is sponsoring clinical trial NCT01115452?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.